Do SGLT2 Inhibitors Improve Cardio-Renal Outcomes in Patients With Type II Diabetes Mellitus: A Systematic Review

Diabetes mellitus (DM) is associated with dreadful changes in the cardiovascular and renal systems, causing increased morbidity and mortality. Sodium-glucose cotransport-2 (SGLT2) inhibitors belong to the oral hypoglycemic group of drugs believed to reduce these events by various mechanisms in DM. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalluri, Sahithi Reddy, Bhutta, Tinaz H, Hannoodee, Hanan, Al Khalili, Mahmoud, Theik, Nyein Wint Yee, Raji, Oluwatimilehin E, Shenwai, Priya, Shah, Rutul, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489544/
https://www.ncbi.nlm.nih.gov/pubmed/34650848
http://dx.doi.org/10.7759/cureus.17668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489544/
https://www.ncbi.nlm.nih.gov/pubmed/34650848
http://dx.doi.org/10.7759/cureus.17668

Ejemplares similares